 Jacob Friedman
Concepts (453)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 35 | 2023 | 2715 | 5.190 |
Why?
| | Diabetes, Gestational | 18 | 2023 | 284 | 4.160 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 11 | 2018 | 32 | 3.380 |
Why?
| | Non-alcoholic Fatty Liver Disease | 11 | 2023 | 277 | 3.300 |
Why?
| | Maternal Nutritional Physiological Phenomena | 11 | 2021 | 157 | 3.090 |
Why?
| | Fatty Liver | 12 | 2014 | 247 | 3.030 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2020 | 465 | 2.960 |
Why?
| | Adiposity | 14 | 2023 | 508 | 2.400 |
Why?
| | Liver | 22 | 2023 | 1803 | 2.390 |
Why?
| | Pregnancy | 60 | 2023 | 5671 | 2.200 |
Why?
| | Muscle, Skeletal | 15 | 2020 | 1515 | 2.060 |
Why?
| | Diet, High-Fat | 8 | 2022 | 247 | 1.580 |
Why?
| | Insulin | 25 | 2022 | 2157 | 1.440 |
Why?
| | Fatty Acids | 5 | 2017 | 403 | 1.430 |
Why?
| | Insulin Resistance | 14 | 2023 | 1167 | 1.410 |
Why?
| | Fetus | 10 | 2023 | 690 | 1.380 |
Why?
| | Pregnancy Complications | 7 | 2018 | 447 | 1.380 |
Why?
| | Gastrointestinal Microbiome | 4 | 2020 | 538 | 1.360 |
Why?
| | Adipogenesis | 4 | 2017 | 47 | 1.310 |
Why?
| | Bone Marrow | 2 | 2023 | 252 | 1.310 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2017 | 66 | 1.280 |
Why?
| | Birth Weight | 7 | 2020 | 463 | 1.260 |
Why?
| | Lipid Metabolism | 14 | 2023 | 473 | 1.220 |
Why?
| | Fetal Development | 5 | 2018 | 250 | 1.140 |
Why?
| | Epigenesis, Genetic | 5 | 2016 | 536 | 1.080 |
Why?
| | Oxidative Stress | 9 | 2022 | 1167 | 1.040 |
Why?
| | DNA Methylation | 6 | 2023 | 501 | 1.030 |
Why?
| | Glucose | 12 | 2023 | 940 | 1.030 |
Why?
| | Fetal Growth Retardation | 8 | 2019 | 468 | 0.990 |
Why?
| | Microbiota | 4 | 2022 | 655 | 0.980 |
Why?
| | Diet, Western | 6 | 2023 | 69 | 0.980 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2023 | 179 | 0.960 |
Why?
| | Inflammation | 10 | 2018 | 2545 | 0.960 |
Why?
| | Animals | 51 | 2023 | 33152 | 0.900 |
Why?
| | Female | 70 | 2023 | 61262 | 0.900 |
Why?
| | Sirtuin 3 | 3 | 2013 | 60 | 0.890 |
Why?
| | Dietary Fats | 4 | 2017 | 323 | 0.880 |
Why?
| | Energy Metabolism | 8 | 2019 | 762 | 0.860 |
Why?
| | PPAR gamma | 5 | 2017 | 187 | 0.860 |
Why?
| | Macrophages | 6 | 2016 | 1311 | 0.840 |
Why?
| | Umbilical Cord | 3 | 2017 | 84 | 0.830 |
Why?
| | Breast Feeding | 3 | 2020 | 381 | 0.800 |
Why?
| | Gluconeogenesis | 8 | 2018 | 65 | 0.790 |
Why?
| | Mitochondria | 7 | 2020 | 785 | 0.790 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2012 | 32 | 0.780 |
Why?
| | Fatty Acids, Omega-3 | 3 | 2022 | 125 | 0.760 |
Why?
| | Infant, Newborn | 17 | 2023 | 5230 | 0.750 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 98 | 0.730 |
Why?
| | Infant Formula | 1 | 2020 | 82 | 0.720 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 359 | 0.720 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 34 | 0.710 |
Why?
| | Maternal Exposure | 2 | 2021 | 140 | 0.700 |
Why?
| | Transgenes | 1 | 2020 | 174 | 0.690 |
Why?
| | Amino Acids | 4 | 2017 | 462 | 0.660 |
Why?
| | Mothers | 6 | 2018 | 675 | 0.650 |
Why?
| | Endoplasmic Reticulum | 3 | 2010 | 240 | 0.650 |
Why?
| | PQQ Cofactor | 2 | 2022 | 5 | 0.650 |
Why?
| | Macrophage Activation | 3 | 2014 | 165 | 0.620 |
Why?
| | Muscle Proteins | 2 | 2014 | 218 | 0.620 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 192 | 0.620 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 0.600 |
Why?
| | Triglycerides | 8 | 2023 | 515 | 0.590 |
Why?
| | Pediatric Obesity | 3 | 2022 | 512 | 0.590 |
Why?
| | Adenylate Kinase | 3 | 2014 | 29 | 0.590 |
Why?
| | Diet | 5 | 2022 | 1143 | 0.590 |
Why?
| | Mice | 21 | 2020 | 15446 | 0.590 |
Why?
| | Metabolic Diseases | 2 | 2017 | 103 | 0.580 |
Why?
| | Hyperlipidemias | 2 | 2016 | 127 | 0.570 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2012 | 341 | 0.560 |
Why?
| | Gene Expression Regulation | 9 | 2019 | 2435 | 0.560 |
Why?
| | Blood Glucose | 11 | 2023 | 1936 | 0.560 |
Why?
| | Niacinamide | 1 | 2016 | 70 | 0.550 |
Why?
| | Adipose Tissue | 5 | 2018 | 595 | 0.530 |
Why?
| | Humans | 56 | 2023 | 118257 | 0.530 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 82 | 0.530 |
Why?
| | Mitochondrial Proteins | 2 | 2014 | 224 | 0.520 |
Why?
| | Infant | 11 | 2022 | 8254 | 0.510 |
Why?
| | Metabolomics | 3 | 2017 | 540 | 0.500 |
Why?
| | Gene Expression | 3 | 2017 | 1482 | 0.490 |
Why?
| | Fenofibrate | 2 | 2016 | 24 | 0.490 |
Why?
| | Cholesterol | 1 | 2016 | 375 | 0.490 |
Why?
| | Antioxidants | 2 | 2023 | 564 | 0.480 |
Why?
| | Insulin Receptor Substrate Proteins | 4 | 2011 | 59 | 0.470 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.470 |
Why?
| | Placenta | 5 | 2021 | 637 | 0.470 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 24 | 0.460 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2010 | 16 | 0.460 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2010 | 227 | 0.460 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2022 | 2159 | 0.460 |
Why?
| | Hepacivirus | 2 | 2012 | 230 | 0.460 |
Why?
| | Macaca | 4 | 2018 | 51 | 0.450 |
Why?
| | Orphan Nuclear Receptors | 1 | 2012 | 14 | 0.450 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2012 | 10 | 0.450 |
Why?
| | Calcium Signaling | 1 | 2014 | 217 | 0.430 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.430 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 70 | 0.430 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 810 | 0.430 |
Why?
| | Atherosclerosis | 1 | 2016 | 345 | 0.430 |
Why?
| | Hypoxia | 1 | 2018 | 957 | 0.420 |
Why?
| | Viral Nonstructural Proteins | 1 | 2012 | 59 | 0.420 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 71 | 0.410 |
Why?
| | Genome, Viral | 1 | 2012 | 123 | 0.410 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 338 | 0.400 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 37 | 0.390 |
Why?
| | Sheep | 8 | 2023 | 762 | 0.390 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 131 | 0.390 |
Why?
| | MicroRNAs | 2 | 2020 | 633 | 0.380 |
Why?
| | Glucose Tolerance Test | 6 | 2018 | 361 | 0.380 |
Why?
| | Signal Transduction | 12 | 2020 | 4688 | 0.360 |
Why?
| | Metformin | 3 | 2023 | 293 | 0.360 |
Why?
| | Lipids | 5 | 2017 | 591 | 0.360 |
Why?
| | Male | 23 | 2020 | 57476 | 0.360 |
Why?
| | Receptors, Adiponectin | 1 | 2009 | 14 | 0.350 |
Why?
| | Phosphorylation | 8 | 2021 | 1622 | 0.350 |
Why?
| | Pre-Eclampsia | 1 | 2012 | 183 | 0.350 |
Why?
| | Phenylbutyrates | 1 | 2009 | 21 | 0.350 |
Why?
| | Glucose Intolerance | 1 | 2011 | 139 | 0.350 |
Why?
| | Sulfonamides | 1 | 2012 | 444 | 0.340 |
Why?
| | Hyperglycemia | 2 | 2020 | 313 | 0.340 |
Why?
| | Liver Neoplasms | 2 | 2010 | 526 | 0.340 |
Why?
| | Adult | 22 | 2022 | 31325 | 0.340 |
Why?
| | RNA, Messenger | 6 | 2017 | 2657 | 0.340 |
Why?
| | Body Mass Index | 8 | 2022 | 2074 | 0.340 |
Why?
| | Biomarkers | 8 | 2023 | 3568 | 0.320 |
Why?
| | Dietary Supplements | 5 | 2022 | 468 | 0.320 |
Why?
| | Primates | 3 | 2023 | 113 | 0.310 |
Why?
| | Up-Regulation | 2 | 2010 | 862 | 0.310 |
Why?
| | Diet, Fat-Restricted | 3 | 2023 | 76 | 0.300 |
Why?
| | Haplorhini | 2 | 2018 | 62 | 0.300 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 59 | 0.290 |
Why?
| | Mice, Inbred C57BL | 6 | 2018 | 4887 | 0.290 |
Why?
| | Oxidation-Reduction | 4 | 2017 | 935 | 0.280 |
Why?
| | Preconception Care | 2 | 2018 | 28 | 0.280 |
Why?
| | Carnitine | 2 | 2017 | 65 | 0.280 |
Why?
| | Postprandial Period | 3 | 2018 | 96 | 0.280 |
Why?
| | Electron Transport | 2 | 2017 | 101 | 0.280 |
Why?
| | Lactation | 2 | 2020 | 156 | 0.280 |
Why?
| | Muscle Development | 2 | 2017 | 102 | 0.280 |
Why?
| | Milk, Human | 2 | 2020 | 134 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1159 | 0.270 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 3 | 2012 | 144 | 0.260 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 155 | 0.260 |
Why?
| | Cytokines | 6 | 2018 | 1880 | 0.260 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2018 | 32 | 0.250 |
Why?
| | Diet, Diabetic | 2 | 2015 | 34 | 0.250 |
Why?
| | Enzyme Activation | 3 | 2012 | 810 | 0.250 |
Why?
| | Hepatocytes | 3 | 2023 | 204 | 0.240 |
Why?
| | Postpartum Period | 4 | 2020 | 267 | 0.240 |
Why?
| | Glucokinase | 1 | 2003 | 13 | 0.240 |
Why?
| | Lipoprotein Lipase | 2 | 2018 | 62 | 0.240 |
Why?
| | Cell Line, Tumor | 5 | 2014 | 2837 | 0.230 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 149 | 0.230 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2003 | 45 | 0.230 |
Why?
| | Mice, Knockout | 6 | 2014 | 2664 | 0.230 |
Why?
| | Prolactin | 1 | 2003 | 96 | 0.230 |
Why?
| | Cyclic AMP | 1 | 2003 | 240 | 0.220 |
Why?
| | Bifidobacterium | 1 | 2022 | 22 | 0.220 |
Why?
| | Blotting, Western | 5 | 2019 | 1186 | 0.220 |
Why?
| | Glucose Clamp Technique | 3 | 2019 | 194 | 0.210 |
Why?
| | Glycerol | 1 | 2022 | 87 | 0.210 |
Why?
| | Progesterone | 1 | 2003 | 242 | 0.210 |
Why?
| | Longitudinal Studies | 3 | 2020 | 2491 | 0.210 |
Why?
| | Insulins | 1 | 2022 | 34 | 0.200 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2012 | 0.200 |
Why?
| | Dexamethasone | 1 | 2003 | 319 | 0.200 |
Why?
| | Forkhead Transcription Factors | 2 | 2012 | 181 | 0.200 |
Why?
| | Cell Differentiation | 4 | 2017 | 1746 | 0.200 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.200 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.200 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 44 | 0.190 |
Why?
| | Response Elements | 2 | 2011 | 82 | 0.190 |
Why?
| | Child | 9 | 2023 | 19033 | 0.180 |
Why?
| | Thapsigargin | 2 | 2010 | 18 | 0.180 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 274 | 0.180 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 243 | 0.180 |
Why?
| | Risk Factors | 6 | 2022 | 8958 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2019 | 980 | 0.180 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 47 | 0.170 |
Why?
| | Body Composition | 5 | 2017 | 644 | 0.170 |
Why?
| | Immune System | 1 | 2020 | 181 | 0.170 |
Why?
| | Phenotype | 4 | 2023 | 2937 | 0.170 |
Why?
| | Germ-Free Life | 1 | 2018 | 30 | 0.170 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 108 | 0.170 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 45 | 0.170 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1157 | 0.170 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 939 | 0.170 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 285 | 0.160 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 47 | 0.160 |
Why?
| | PPAR alpha | 3 | 2022 | 55 | 0.160 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1590 | 0.160 |
Why?
| | Fetal Macrosomia | 1 | 2018 | 56 | 0.160 |
Why?
| | Rats | 4 | 2012 | 5339 | 0.160 |
Why?
| | Micronutrients | 1 | 2018 | 78 | 0.160 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 38 | 0.160 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.150 |
Why?
| | Niacin | 1 | 2017 | 20 | 0.150 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 179 | 0.150 |
Why?
| | Islets of Langerhans | 1 | 2003 | 739 | 0.150 |
Why?
| | Hypoglycemic Agents | 3 | 2018 | 1031 | 0.150 |
Why?
| | Immunity, Innate | 1 | 2023 | 744 | 0.150 |
Why?
| | Bone Marrow Cells | 2 | 2016 | 273 | 0.150 |
Why?
| | Dysbiosis | 1 | 2018 | 148 | 0.150 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 79 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2020 | 418 | 0.150 |
Why?
| | Computational Biology | 1 | 2020 | 541 | 0.140 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 287 | 0.140 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 9 | 0.140 |
Why?
| | Sirtuin 1 | 1 | 2016 | 30 | 0.140 |
Why?
| | Foam Cells | 1 | 2016 | 15 | 0.140 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 165 | 0.140 |
Why?
| | Gestational Age | 5 | 2019 | 765 | 0.140 |
Why?
| | Myoblasts | 1 | 2017 | 75 | 0.140 |
Why?
| | Ceramides | 1 | 2016 | 96 | 0.140 |
Why?
| | Feces | 1 | 2018 | 392 | 0.140 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 42 | 0.140 |
Why?
| | Colitis | 1 | 2018 | 219 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 167 | 0.140 |
Why?
| | Plethysmography | 1 | 2016 | 124 | 0.140 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 64 | 0.140 |
Why?
| | Nutritional Status | 2 | 2018 | 298 | 0.140 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 357 | 0.130 |
Why?
| | Gene Deletion | 2 | 2018 | 359 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2016 | 685 | 0.130 |
Why?
| | Gene Silencing | 1 | 2016 | 177 | 0.130 |
Why?
| | Cohort Studies | 3 | 2015 | 5078 | 0.130 |
Why?
| | 3T3-L1 Cells | 2 | 2012 | 35 | 0.130 |
Why?
| | Glucose-6-Phosphatase | 2 | 2012 | 32 | 0.130 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 192 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2016 | 4044 | 0.130 |
Why?
| | Hematopoiesis | 1 | 2016 | 176 | 0.130 |
Why?
| | Space Flight | 1 | 2016 | 129 | 0.130 |
Why?
| | Cell Division | 1 | 2017 | 775 | 0.130 |
Why?
| | Adolescent | 7 | 2023 | 18364 | 0.130 |
Why?
| | Awards and Prizes | 1 | 2015 | 56 | 0.130 |
Why?
| | Endocrinology | 1 | 2015 | 68 | 0.120 |
Why?
| | Young Adult | 7 | 2018 | 10731 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 290 | 0.120 |
Why?
| | Maternal Welfare | 1 | 2014 | 15 | 0.120 |
Why?
| | Bacteria | 1 | 2020 | 751 | 0.120 |
Why?
| | Glucose Transporter Type 4 | 2 | 2006 | 38 | 0.120 |
Why?
| | Overweight | 2 | 2015 | 492 | 0.120 |
Why?
| | Animal Feed | 1 | 2014 | 55 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 817 | 0.120 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 156 | 0.120 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 529 | 0.120 |
Why?
| | Nutrition Assessment | 1 | 2014 | 77 | 0.120 |
Why?
| | Dietary Fiber | 1 | 2013 | 42 | 0.120 |
Why?
| | Disease Progression | 1 | 2020 | 2477 | 0.110 |
Why?
| | Body Weight | 4 | 2016 | 923 | 0.110 |
Why?
| | Intestines | 2 | 2013 | 330 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1004 | 0.110 |
Why?
| | Sheep, Domestic | 2 | 2019 | 32 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2019 | 3676 | 0.110 |
Why?
| | Dietary Carbohydrates | 1 | 2014 | 157 | 0.110 |
Why?
| | Liver X Receptors | 1 | 2012 | 30 | 0.110 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2012 | 24 | 0.110 |
Why?
| | Forkhead Box Protein O1 | 1 | 2012 | 15 | 0.110 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2017 | 2262 | 0.110 |
Why?
| | Enzyme Induction | 1 | 2012 | 92 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 979 | 0.110 |
Why?
| | Adipocytes | 2 | 2017 | 195 | 0.110 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 79 | 0.110 |
Why?
| | Lipogenesis | 1 | 2012 | 66 | 0.110 |
Why?
| | Luciferases | 1 | 2012 | 142 | 0.110 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 279 | 0.110 |
Why?
| | Transcription Factor RelA | 1 | 2012 | 79 | 0.110 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 198 | 0.100 |
Why?
| | Endotoxins | 2 | 2023 | 234 | 0.100 |
Why?
| | Glutathione | 1 | 2013 | 324 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2012 | 268 | 0.100 |
Why?
| | Receptor, Insulin | 4 | 2007 | 100 | 0.100 |
Why?
| | Retinoid X Receptor alpha | 1 | 2011 | 4 | 0.100 |
Why?
| | Prenatal Care | 1 | 2014 | 252 | 0.100 |
Why?
| | Colorado | 2 | 2020 | 4178 | 0.100 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.100 |
Why?
| | Random Allocation | 3 | 2023 | 344 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2017 | 1048 | 0.100 |
Why?
| | Proteomics | 2 | 2014 | 850 | 0.100 |
Why?
| | Risk Assessment | 1 | 2020 | 3043 | 0.100 |
Why?
| | Inflammasomes | 1 | 2012 | 120 | 0.100 |
Why?
| | Hydrocortisone | 1 | 2012 | 272 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2010 | 17 | 0.090 |
Why?
| | NAD | 1 | 2011 | 67 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 505 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1795 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 198 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1433 | 0.090 |
Why?
| | Serine | 1 | 2011 | 137 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2012 | 304 | 0.090 |
Why?
| | Tyrosine | 1 | 2011 | 227 | 0.090 |
Why?
| | Caloric Restriction | 1 | 2011 | 91 | 0.090 |
Why?
| | Virus Replication | 1 | 2012 | 398 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 287 | 0.090 |
Why?
| | Tunicamycin | 1 | 2009 | 11 | 0.090 |
Why?
| | Cell Line | 2 | 2007 | 2693 | 0.090 |
Why?
| | Fibroblasts | 1 | 2014 | 835 | 0.090 |
Why?
| | Mesoderm | 1 | 2010 | 142 | 0.090 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 34 | 0.090 |
Why?
| | Myeloid Cells | 1 | 2010 | 127 | 0.090 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.090 |
Why?
| | CREB-Binding Protein | 1 | 2008 | 28 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2008 | 61 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2009 | 86 | 0.080 |
Why?
| | Animals, Newborn | 3 | 2017 | 804 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 725 | 0.080 |
Why?
| | Time Factors | 3 | 2012 | 6368 | 0.080 |
Why?
| | Child Development | 1 | 2012 | 402 | 0.080 |
Why?
| | Placental Insufficiency | 1 | 2009 | 104 | 0.080 |
Why?
| | Wnt Proteins | 1 | 2008 | 140 | 0.080 |
Why?
| | Protein Binding | 2 | 2010 | 1969 | 0.080 |
Why?
| | Choline Deficiency | 1 | 2007 | 12 | 0.080 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 39 | 0.080 |
Why?
| | Models, Genetic | 1 | 2010 | 592 | 0.080 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 38 | 0.080 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 26 | 0.080 |
Why?
| | Palmitates | 1 | 2007 | 18 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 23 | 0.080 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 28 | 0.080 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 56 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases | 2 | 2008 | 21 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2010 | 414 | 0.070 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 56 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 1937 | 0.070 |
Why?
| | Histones | 1 | 2012 | 546 | 0.070 |
Why?
| | Age Factors | 2 | 2011 | 2990 | 0.070 |
Why?
| | Lipase | 1 | 2007 | 67 | 0.070 |
Why?
| | Phosphoproteins | 3 | 2006 | 303 | 0.070 |
Why?
| | Fibrosis | 2 | 2023 | 480 | 0.070 |
Why?
| | Hormones | 1 | 2007 | 135 | 0.070 |
Why?
| | Methionine | 1 | 2007 | 145 | 0.070 |
Why?
| | Adiponectin | 2 | 2018 | 224 | 0.070 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 42 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 935 | 0.070 |
Why?
| | Reference Values | 1 | 2007 | 770 | 0.070 |
Why?
| | Pilot Projects | 2 | 2023 | 1405 | 0.070 |
Why?
| | Fasting | 2 | 2018 | 256 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1161 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2262 | 0.060 |
Why?
| | Glycemic Index | 2 | 2015 | 23 | 0.060 |
Why?
| | RNA | 1 | 2011 | 830 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 808 | 0.060 |
Why?
| | Insulin Antagonists | 1 | 2003 | 6 | 0.060 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2015 | 162 | 0.060 |
Why?
| | Keto Acids | 1 | 2003 | 13 | 0.060 |
Why?
| | NF-kappa B | 1 | 2007 | 664 | 0.060 |
Why?
| | C-Peptide | 1 | 2023 | 139 | 0.060 |
Why?
| | Leptin | 2 | 2018 | 228 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1784 | 0.060 |
Why?
| | Drug Synergism | 1 | 2003 | 338 | 0.060 |
Why?
| | Prospective Studies | 3 | 2022 | 6443 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2020 | 369 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2020 | 1237 | 0.050 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2002 | 46 | 0.050 |
Why?
| | Fetal Blood | 1 | 2023 | 270 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 253 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3169 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 150 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1675 | 0.050 |
Why?
| | Myocardium | 1 | 2006 | 965 | 0.050 |
Why?
| | Uterus | 1 | 2021 | 197 | 0.050 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.050 |
Why?
| | Patient Compliance | 2 | 2014 | 532 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2022 | 4574 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1567 | 0.040 |
Why?
| | Models, Biological | 2 | 2010 | 1701 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 96 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 21 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 545 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 380 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 186 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1082 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 857 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 2012 | 395 | 0.040 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2022 | 785 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 700 | 0.040 |
Why?
| | Cell Size | 1 | 2017 | 83 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 126 | 0.040 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 62 | 0.040 |
Why?
| | Guatemala | 1 | 2018 | 296 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 9319 | 0.040 |
Why?
| | Diet Surveys | 1 | 2017 | 84 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2020 | 1072 | 0.040 |
Why?
| | Child, Preschool | 2 | 2021 | 9448 | 0.040 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.040 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.040 |
Why?
| | Obstetrics | 1 | 2018 | 162 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 556 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 623 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 57 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 86 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 445 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2020 | 951 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2014 | 37 | 0.030 |
Why?
| | Health | 1 | 2015 | 80 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 21 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 701 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 74 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 304 | 0.030 |
Why?
| | Dietary Sucrose | 1 | 2013 | 55 | 0.030 |
Why?
| | Prediabetic State | 1 | 2016 | 228 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 752 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1857 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 244 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 186 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2014 | 456 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 198 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 2012 | 115 | 0.030 |
Why?
| | Leucine | 1 | 2012 | 117 | 0.030 |
Why?
| | Proteolysis | 1 | 2012 | 146 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 122 | 0.030 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2011 | 8 | 0.030 |
Why?
| | Milk | 1 | 2012 | 125 | 0.030 |
Why?
| | Cattle | 1 | 2014 | 974 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1202 | 0.020 |
Why?
| | Pregnancy Outcome | 1 | 2013 | 349 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2011 | 43 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2011 | 73 | 0.020 |
Why?
| | Cell Respiration | 1 | 2011 | 76 | 0.020 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 6 | 0.020 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 28 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3156 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 216 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 330 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3424 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 664 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 53 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 316 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 23 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 764 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 25 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 154 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4522 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 226 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2008 | 107 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 541 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 306 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 59 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 600 | 0.020 |
Why?
| | Binding Sites | 1 | 2008 | 1221 | 0.020 |
Why?
| | Organ Size | 1 | 2006 | 460 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2855 | 0.020 |
Why?
| | Sex Factors | 1 | 2010 | 1765 | 0.020 |
Why?
| | Fever | 1 | 2006 | 283 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 403 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 401 | 0.010 |
Why?
| | United States | 1 | 2018 | 12491 | 0.010 |
Why?
| | Aged | 1 | 2016 | 19594 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3435 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12929 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 27511 | 0.010 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|